September 9 – 12, 2019

Westin Boston Waterfront

Boston, MA

Development and Commercialization of CDx in the Era of Precision Medicine

Wednesday October 3 | 9am – 12.30pm

Bringing a precision medicine and companion diagnostic from concept to patient has multiple complex moving parts and requires strong collaboration internally, with partners and external bodies. To ensure your drug-Dx product is pushing the boundaries of the standard of care, you have to be at the cutting edge of biomarker and technology developments as well as commercial and market access strategy.

Join Covance and their panel of industry expert speakers to take a deeper dive into the process from biomarker to commercial drug-Dx product. Benefit from multi-stakeholder perspectives, granular discussion and extended networking as this workshop guides you the through cutting edge biomarker and diagnostic technology updates and provides you a blueprint on developing a global commercial blueprint.